NCT04442932 is a clinical trial of Blood Collection in Allergy, sponsored by Abionic SA.

Who is sponsoring NCT04442932?

NCT04442932 is sponsored by Abionic SA.

What drugs are being tested in NCT04442932?

Interventions in NCT04442932: Blood Collection.

What condition does NCT04442932 study?

NCT04442932 studies Allergy, Allergic Asthma, Allergy to Cats, Allergy to House Dust, Allergy to Dog Dander, Allergy Cockroach.

Is NCT04442932 still recruiting?

NCT04442932 is currently withdrawn. Last updated 5 October 2020.

Last reviewed 2020-10-05 · How we verify

NCT04442932

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

abioSCOPE IgE Assay to Aid in the Diagnosis of Allergies

Withdrawn Last updated 5 October 2020

What this trial tests

trial testing Blood Collection in Allergy. Withdrawn.

Timeline

15 November 2020

Primary endpoint
31 December 2020

15 March 2021

Quick facts

Lead sponsor	Abionic SA
Status	Withdrawn
Study type	OBSERVATIONAL
Start date	15 November 2020
Primary completion	31 December 2020
Estimated completion	15 March 2021
Sites	5 locations across United States

Drugs / interventions tested

Blood Collection — full drug profile →

Conditions studied

Allergy — all drugs for Allergy →
Allergic Asthma — all drugs for Allergic Asthma →
Allergy to Cats — all drugs for Allergy to Cats →
Allergy to House Dust — all drugs for Allergy to House Dust →

Sponsor

Abionic SA

Who can join

6 and older, any sex, with Allergy or Allergic Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a multicenter, prospective, observational study designed to determine the clinical sensitivity and specificity of the Abionic IVD CAPSULE Allergic Asthma panel performed on Abionic's abioSCOPE device using K3-EDTA anticoagulated plasma samples from atopic and non-atopic pediatric and adult patients. Patients' sensitization determined with the abioSCOPE will be compared to the clinical assessment of allergy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Blood Collection

Trials testing the same drug.

NCT06804057 — CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry · recruiting
NCT05716022 — Hiatal Hernia and Pulmonary Involvement · completed
NCT05324553 — Patient Derived Preclinical Models · recruiting
NCT05051722 — Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer · recruiting
NCT04103333 — Angelman Syndrome (AS) Biomarker Study · EARLY_PHASE1 · completed

Other recruiting trials for Allergy

Currently open trials in the same condition.

NCT05997784 — Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing · active not recruiting
NCT06390878 — Nationwide Research on the Rewilding of Kindergarten Yards · NA · recruiting
NCT06248957 — SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION · recruiting
NCT05449756 — A Follow-up Study With Children Who Participated in the TEMPO Study in Their First Year of Life · recruiting
NCT06192914 — EPAP, Interviewstudy · recruiting

Other Abionic SA trials

Trials by the same sponsor.

NCT05849935 — abioSCOPE PSP Reference Range Study; Extension of AB-PSP-003 · completed
NCT05596032 — Prospective Study to Validate the Diagnostic Performance of IVD CAPSULE COVID-19-NP Test for the Detection of SARS-CoV-2 · completed
NCT05627076 — Analytical Validation of the abioSCOPE Device With the IVD CAPSULE PSP Test: Comparison of PSP Values Measured With Veno · completed
NCT04409561 — Reference Range for abioSCOPE® Device With the PSP Assay in a Generally Healthy Adult Population · completed
NCT04105699 — Evaluation of Immunoassay Measurements of Pancreatic Stone Protein Performed on abioSCOPE® Device With the PSP Assay on · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04442932 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Abionic SA
Last refreshed: 5 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04442932.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing